Innovative Approaches in the Assessment of Lipödem Pain
The study by Bettariga et al. (2024) [1] constitutes a valuable step towards filling a significant gap in the objective evaluation of chronic pain in lipödem patients. Until now, in the diagnosis and follow-up of lipödem, pain was generally based on patients' subjective expressions (scales like VAS, NRS) and the physician's experience in palpation examination. This situation could both delay diagnosis and make objective follow-up of treatment effectiveness difficult.
The most significant innovation this study brings to the literature is its first comprehensive examination of the reliability and validity of pain assessments made using both pain pressure threshold (PPT – Pain Pressure Threshold) measurement with a digital algometer and a hand-held sphygmomanometer (HHS – Hand-Held Sphygmomanometer) in lipödem patients. When evaluating lipödem patients in my clinic, the subjective nature of sensitivity and pain, especially in the legs, has always driven me to seek more objective measurement. At this point, although algometer use is preferred in some specialized clinics, its cost and accessibility can be limiting.
Implications for Clinical Practice and Reliability
The research results showed that both PPT and HHS methods have 'excellent' reliability (ICC 0.93-0.97 and 0.96-0.97, respectively) for pain assessment in lipödem patients. This means that both methods offer repeatable and consistent measurements, which is of vital importance for clinical decision-making processes. Especially the good level of validity demonstrated by HHS with PPT (R² values of 69-74%) reveals the potential for this inexpensive and easily accessible tool to be used as an objective measurement method to assist in lipödem diagnosis. In geographies like Turkey, where cost-effective solutions in healthcare are gaining importance, I believe this situation presents a great opportunity for the widespread adoption and standardization of lipödem diagnosis.
Previous studies by Dinnendahl et al. (2024) [2] also showed that PPT values in the legs of lipödem patients were significantly lower than in healthy individuals. The findings by Bettariga et al. support this observation, once again confirming the presence of hyperalgesia and pain sensitivity in lipödem. This emphasizes how much pain in lipödem diagnosis can be a distinguishing parameter. In my experience, the unique tension and sensitivity felt in the tissues of lipödem patients is an important clue in differentiating it from other adipose tissue disorders (e.g., simple lipohypertrophy) and these measurements can objectify this subjective feeling.
Future Research and Application Areas
The study's limitations include a small sample size and its focus solely on the calf region. However, this lays a solid foundation for future research on how pain assessment can be performed in different stages of lipödem and in other body regions (e.g., thighs, arms). The application of these methods in a wider patient population and in different lipödem stages in our clinic will enable the development of lipödem diagnostic criteria specific to Turkey and contribute to the international literature. Extensive studies on lipödem care, such as Herbst et al. (2021) [3], constantly emphasize the need for objective assessment tools. This study offers a practical and accessible answer to this need.
In conclusion, this study by Bettariga et al. provides two reliable and valid methods for the objective measurement of pain in lipödem patients, making significant contributions to the diagnosis and follow-up of this chronic condition. Especially the emergence of the hand-held sphygmomanometer as a practical and cost-effective alternative creates a strong rationale for its widespread adoption in clinical practices. I believe these developments are a valuable step towards improving the quality of life for lipödem patients.